Exact Sciences announced this week that Cologuard could be included in the 2017 Healthcare Effectiveness Data and Information Set (HEDIS) quality measures for colorectal cancer screening following a proposal from the…
SHINE Medical Technologies announced today that is has entered into a strategic agreement with the largest Chinese producer and distributor of radio-pharmaceuticals, HTA, to help with the supply of molybdenum (moly-99). “HTA…
Exact Sciences is now an in-network provider of Cologuard with Anthem Blue Cross and Blue Shield in five additional states, the organization announced Wednesday. “As Cologuard’s in-network status grows in…
The U.S. Patent and Trademark Office has awarded Cellectar Biosciences a patent that covers CLR 1603, a phospholipid ether-paclitaxel conjugate, the company announced recently. “This first issued patent under our CLR CTX…
To provide resources for developing new therapies, Cellular Dynamics International, a FUJIFILM company, announced Wednesday a partnership with The Michael J. Fox Foundation for Parkinson’s Research. “Our partnership with The…
Stemina Biomarker Discovery Inc., is rebranding its diagnostics to more accurately represent its focus on neurological disorders, the company announced recently. According to a release, NeuroPointDX, a division of Stemina,…
Exact Sciences announced today that approximately 40,000 Cologuard tests were completed in the first quarter of 2016. “Our first quarter performance reflects sequential growth and another significant year-over-year increase, the result…
Greg Piefer is ambitious, to say the least. The CEO of SHINE Medical Technologies expects his company to create a reliable supply of the medical ingredients, including molybdenum-99, required by nearly…
Cellectar Biosciences‘ public offering raised $8 million, the company announced today. “We are pleased with the results of this offering, including the underwriter’s exercise of their full over-allotment option,” Cellectar…
To improve adherence and care management for people living with COPD and asthma, Propeller Health today announced it will partner with global pharmaceutical company Boehringer Ingelheim. “We are excited to…
